- Home
- MOVE vs LPCN Comparison
MOVE vs LPCN Comparison
Compare MOVE & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOVE
- LPCN
- Stock Information
- Founded
- MOVE 2018
- LPCN 1997
- Country
- MOVE United States
- LPCN United States
- Employees
- MOVE N/A
- LPCN N/A
- Industry
- MOVE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- LPCN Biotechnology: Pharmaceutical Preparations
- Sector
- MOVE Health Care
- LPCN Health Care
- Exchange
- MOVE Nasdaq
- LPCN Nasdaq
- Market Cap
- MOVE 25.9M
- LPCN 27.1M
- IPO Year
- MOVE 2021
- LPCN N/A
- Fundamental
- Price
- MOVE $5.63
- LPCN $4.37
- Analyst Decision
- MOVE Buy
- LPCN Strong Buy
- Analyst Count
- MOVE 1
- LPCN 1
- Target Price
- MOVE $30.00
- LPCN $10.00
- AVG Volume (30 Days)
- MOVE 22.9K
- LPCN 34.0K
- Earning Date
- MOVE 11-14-2024
- LPCN 03-06-2025
- Dividend Yield
- MOVE N/A
- LPCN N/A
- EPS Growth
- MOVE N/A
- LPCN N/A
- EPS
- MOVE N/A
- LPCN N/A
- Revenue
- MOVE $902,000.00
- LPCN $7,922,926.00
- Revenue This Year
- MOVE N/A
- LPCN N/A
- Revenue Next Year
- MOVE $545.31
- LPCN N/A
- P/E Ratio
- MOVE N/A
- LPCN N/A
- Revenue Growth
- MOVE N/A
- LPCN N/A
- 52 Week Low
- MOVE $2.80
- LPCN $3.20
- 52 Week High
- MOVE $11.70
- LPCN $11.79
- Technical
- Relative Strength Index (RSI)
- MOVE 51.26
- LPCN 38.51
- Support Level
- MOVE $5.45
- LPCN $4.48
- Resistance Level
- MOVE $5.99
- LPCN $4.89
- Average True Range (ATR)
- MOVE 0.34
- LPCN 0.35
- MACD
- MOVE -0.04
- LPCN -0.06
- Stochastic Oscillator
- MOVE 54.60
- LPCN 9.60
About MOVE Movano Inc.
Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.